BlackRock Group’s Enzo Biochem, Inc. ENZ Stock Holding History

BlackRock Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-28,472	Closed	-$128K	–	3069
2015 Q4	$128K	Hold	28,472	–	–	﹤0.01%	2614
2015 Q3	$90K	Hold	28,472	–	–	﹤0.01%	2729
2015 Q2	$86K	Hold	28,472	–	–	﹤0.01%	2791
2015 Q1	$84K	Buy	+28,472	New	+$93.2K	﹤0.01%	2687
2014 Q2	–	Sell	-76,562	Closed	-$318K	–	2873
2014 Q1	$318K	Buy	+76,562	New	+$262K	﹤0.01%	2359

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

BlackRock Group's ENZ Position: Q1 2016 in Review

BlackRock Group sold out of Enzo Biochem, Inc. (ENZ) in Q1 2016, closing a stake of 28,472 shares — an estimated $128K sold.

BlackRock Group first reported a position in ENZ in Q1 2014 and held it in 5 quarters. The position peaked at $318K in Q1 2014. 99 funds tracked by Wall St. Rank hold ENZ as of Q1 2016.

BlackRock Group reported no remaining Enzo Biochem, Inc. position as of Q1 2016 after selling out during the quarter.
BlackRock Group sold 28,472 Enzo Biochem, Inc. shares in Q1 2016, an estimated $128K.
BlackRock Group first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 5 quarters.
BlackRock Group's Enzo Biochem, Inc. position peaked at $318K in Q1 2014.
99 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2016.

Based on BlackRock Group's 13F filing for Q1 2016, filed 10 May 2016.